RGA EVP Ozeki settles RSUs into common stock

Reinsurance Group of America executive Arthur Ozeki, EVP and Head of Asia Pacific, reported the vesting and settlement of previously granted restricted share units into common stock on January 15, 2026.

Rhea-AI Filing Summary

Reinsurance Group of America executive Arthur Ozeki, EVP and Head of Asia Pacific, reported the vesting and settlement of previously granted restricted share units into common stock on January 15, 2026. Three RSU awards were converted: 232 shares from the March 2025 grant, 153 shares from the March 2024 grant, and 576 shares from the March 2023 grant, each on a one-for-one basis into common stock at an exercise price of $0.00 per unit.

These RSUs were part of long-term equity awards that vest over time, with the March 2025 grant scheduled to fully vest on December 31, 2027, the March 2024 grant on December 31, 2026, and the March 2023 grant on December 31, 2025. Following these settlements, Ozeki directly owns 10,347 shares of Reinsurance Group of America common stock, and the reported RSU positions show zero derivative units remaining from these specific grants.

Insider Trade Summary

961 shares exercised/converted

Exercise 6 txns

Insider Ozeki Arthur

Role EVP, Head of Asia Pacific

Type	Security	Shares	Price	Value
Exercise	Restricted Share Unit - March 2025	232	$0.00	$0.00
Exercise	Restricted Share Unit - March 2024	153	$0.00	$0.00
Exercise	Restricted Share Unit - March 2023	576	$0.00	$0.00
Exercise	Common stock	232	$0.00	$0.00
Exercise	Common stock	153	$0.00	$0.00
Exercise	Common stock	576	$0.00	$0.00

Holdings After Transaction: Restricted Share Unit - March 2025 — 0 contracts (Direct); Restricted Share Unit - March 2024 — 0 contracts (Direct); Restricted Share Unit - March 2023 — 0 contracts (Direct); Common stock — 10,347 shares (Direct)

Footnotes (4)

1. F1. Restricted share units granted on March 6, 2025, vest in 33 and 1/3% increments over three years, and fully vest on December 31, 2027.
2. F2. Each restricted share unit represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
3. F3. Restricted share units granted on March 15, 2024, vest in 33 and 1/3% increments over three years, and fully vest on December 31, 2026.
4. F4. Restricted share units granted on March 9, 2023, fully vest on December 31, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did RGA EVP Arthur Ozeki report on this Form 4 for RGA?

Arthur Ozeki reported the vesting and settlement of restricted share units into Reinsurance Group of America common stock on January 15, 2026, converting RSUs from March 2023, March 2024, and March 2025 grants into common shares at $0.00 per unit.

How many Reinsurance Group of America RSUs vested for Arthur Ozeki in this filing for RGA?

On January 15, 2026, restricted share units for 232 shares from the March 2025 grant, 153 shares from the March 2024 grant, and 576 shares from the March 2023 grant each converted into an equal number of Reinsurance Group of America common shares.

What is Arthur Ozekis RGA common stock holding after these RSU settlements?

After the reported transactions, Arthur Ozeki directly owns 10,347 shares of Reinsurance Group of America common stock, as shown in the Form 4 table for non-derivative securities.

Were any Reinsurance Group of America shares sold by Arthur Ozeki in this Form 4?

The Form 4 shows transaction code M for all entries, indicating derivative settlements or exercises, and reports the acquisition of common stock from RSU settlements; it does not report any sales transaction code.

How do the RGA restricted share units for Arthur Ozeki vest over time?

The March 6, 2025 RSUs vest in 33 1/3% increments over three years and fully vest on December 31, 2027. The March 15, 2024 RSUs also vest in 33 1/3% yearly increments and fully vest on December 31, 2026. The March 9, 2023 RSUs fully vest on December 31, 2025.

What does each Reinsurance Group of America RSU represent in this RGA Form 4?

Each restricted share unit reported represents a contingent right to receive one share of Reinsurance Group of America common stock upon settlement, according to the explanation of responses.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/20/2026 - 08:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ozeki Arthur

(Last) (First) (Middle)

16600 SWINGLEY RIDGE ROAD

(Street)

CHESTERFIELD MO 63017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
REINSURANCE GROUP OF AMERICA INC [ RGA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Head of Asia Pacific

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	01/15/2026		M		232(1)(2)	A	(1)(2)	9,618	D
Common stock	01/15/2026		M		153(2)(3)	A	(2)(3)	9,771	D
Common stock	01/15/2026		M		576(2)(4)	A	(2)(4)	10,347	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Unit - March 2025	$193(2)	01/15/2026		M			232	12/31/2027	(1)	Common Stock	232	(1)	0	D
Restricted Share Unit - March 2024	$185.28(2)	01/15/2026		M			153	12/31/2026	(3)	Common stock	153	(3)	0	D
Restricted Share Unit - March 2023	$138.34(2)	01/15/2026		M			576	12/31/2025	(4)	Common stock	576	(4)	0	D

Explanation of Responses:

1. Restricted share units granted on March 6, 2025, vest in 33 and 1/3% increments over three years, and fully vest on December 31, 2027.

2. Each restricted share unit represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.

3. Restricted share units granted on March 15, 2024, vest in 33 and 1/3% increments over three years, and fully vest on December 31, 2026.

4. Restricted share units granted on March 9, 2023, fully vest on December 31, 2025.

Remarks:

	/s/ My Chi To, by Power of Attorney	01/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.